199 related articles for article (PubMed ID: 20035975)
1. Identification of a microRNA panel for clear-cell kidney cancer.
Juan D; Alexe G; Antes T; Liu H; Madabhushi A; Delisi C; Ganesan S; Bhanot G; Liou LS
Urology; 2010 Apr; 75(4):835-41. PubMed ID: 20035975
[TBL] [Abstract][Full Text] [Related]
2. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
3. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
5. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
Faragalla H; Youssef YM; Scorilas A; Khalil B; White NM; Mejia-Guerrero S; Khella H; Jewett MA; Evans A; Lichner Z; Bjarnason G; Sugar L; Attalah MI; Yousef GM
J Mol Diagn; 2012 Jul; 14(4):385-92. PubMed ID: 22580180
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
8. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
Chow TF; Mankaruos M; Scorilas A; Youssef Y; Girgis A; Mossad S; Metias S; Rofael Y; Honey RJ; Stewart R; Pace KT; Yousef GM
J Urol; 2010 Feb; 183(2):743-51. PubMed ID: 20022054
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of microRNA expression in renal clear cell carcinoma.
Huang Y; Dai Y; Yang J; Chen T; Yin Y; Tang M; Hu C; Zhang L
Eur J Surg Oncol; 2009 Oct; 35(10):1119-23. PubMed ID: 19443172
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.
Li H; Zhao J; Zhang JW; Huang QY; Huang JZ; Chi LS; Tang HJ; Liu GQ; Zhu DJ; Ma WM
Neoplasma; 2013; 60(5):511-5. PubMed ID: 23790169
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.
Hauser S; Wulfken LM; Holdenrieder S; Moritz R; Ohlmann CH; Jung V; Becker F; Herrmann E; Walgenbach-Brünagel G; von Ruecker A; Müller SC; Ellinger J
Cancer Epidemiol; 2012 Aug; 36(4):391-4. PubMed ID: 22542158
[TBL] [Abstract][Full Text] [Related]
12. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
13. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
[TBL] [Abstract][Full Text] [Related]
14. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
[TBL] [Abstract][Full Text] [Related]
16. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library.
Tang SW; Chang WH; Chao YW; Lin CY; Chen HF; Lai YH; Zhan BW; Su YC; Jane SW; Chen YC; Hsu CI; Lin WC; Wang KC; Lai MK; Lin JY
J Biomed Sci; 2006 Mar; 13(2):233-40. PubMed ID: 16453177
[TBL] [Abstract][Full Text] [Related]
19. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
Guo Y; Chen Z; Zhang L; Zhou F; Shi S; Feng X; Li B; Meng X; Ma X; Luo M; Shao K; Li N; Qiu B; Mitchelson K; Cheng J; He J
Cancer Res; 2008 Jan; 68(1):26-33. PubMed ID: 18172293
[TBL] [Abstract][Full Text] [Related]
20. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
